Neoadjuvant Chemotherapy: Transforming Treatmen...

By Rene Pretorius

October 25, 2024

Neoadjuvant chemotherapy (NACT) followed by interval cytoreductive surgery (ICS) has become the leading initial treatment for advanced epithelial ovarian cancer (EOC). This approach offers ad...
Rifaximin Use Linked to Daptomycin Resistance: Implications for Antibiotic St...
CTO-PCI Technology for Heart Health in Egypt
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Telemedicine Growth in the MENA Region: A Digital Healthcare Revolution
Saudi Healthcare Reform: Vision 2030 and Beyond
Transforming Value-Based Oncology Care: A Multifaceted Approach
Bupa Launches Whole Genome Sequencing Pilot in UK
HARMONi-2 Trial Results Transforming NSCLC
KEYTRUDA Head Neck Cancer Phase 3 Trial
Rising Hearing Loss in Africa by 2030: Urgent Measures Needed
A Decade of Ethical Healthcare Collaboration
UNAIDS Urges Greater Access for Gilead’s Lenacapavir